about
Anticoagulation for people receiving long-term haemodialysisOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationVenous thromboembolism prophylaxis for acute spinal cord injury patientsNo influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic strokeAn update on recent patents on thrombin inhibitors (2010 - 2013)Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesA network-based multi-target computational estimation scheme for anticoagulant activities of compoundsNew synthetic thrombin inhibitors: molecular design and experimental verificationThrombus formation in left atrium on dabigatran therapy.Argatroban in extracorporeal membrane oxygenation.Latest medical treatment strategies for venous thromboembolism.Pharmacodynamic and efficacy profile of TGN 255, a novel direct thrombin inhibitor, in canine cardiopulmonary bypass and simulated mitral valve repair.Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudinDabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Direct thrombin inhibitors.Safety of bivalirudin in patients with coronary artery disease.The management of suspected heparin-induced thrombocytopenia in US hospitals.Reversible crystallization of argatroban after subcutaneous application in pigs.Heparin-induced thrombocytopenia in the pediatric population: a review of current literatureUpdate on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IIAnticoagulation with bivalirudin during deep hypothermic circulatory arrest in a patient with heparin-induced thrombocytopeniaBivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy.Argatroban for an alternative anticoagulant in HIT during ECMO.In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.Microfluidic platform for combinatorial synthesis in picolitre droplets.In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors.LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screeningNovel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.Oral heparin: status reviewExtracellular proteases as targets for drug developmentDiscovery methodology for the development of direct factor VIIa inhibitors.Stroke Prevention in Atrial Fibrillation: Where are We Now?Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report.A systematic review on the use of new anticoagulants in pregnancy.
P2860
Q24187603-66A0C671-9320-4CFC-8D85-5130C40E5978Q24203797-E1197A2F-4AA0-40F4-9213-D9F35CD3F22BQ24239926-4C1FD05D-76B2-44BE-9EB9-8F1619CB230AQ27334041-5C59A83B-1765-4CC1-A0FE-2B40C5C14C45Q28299898-79D0891B-545C-4767-B03B-B4E2C4C40247Q28469258-71990211-4EF5-4D05-B4B5-28395328D28CQ28477458-40CC0C4F-06F0-4BF1-AB88-5264D438A206Q28744536-D9DA7349-706B-4307-95CD-C9354574966DQ30625534-BA4F1D73-A789-4C1B-9A2C-B75116F1AD1AQ33375421-1BFC6750-DB4D-4D17-8C7F-97C8210B18BDQ33375535-E649EFA7-C5B4-4956-9573-ECFA20541157Q33380778-D062D9F4-D75B-4D4D-A098-BAD1764F7398Q33381356-612B1327-294E-4E74-9063-B33897DFDC94Q33381801-62CC5300-B8B6-443E-9A87-9B2F82E64931Q33385970-1493F207-918E-4019-97D3-727A4D2D9065Q33393692-02FF3877-2CB7-46A7-88A4-544B8FCF1B49Q33397635-281E1F00-4A2E-4B7B-93B6-2131CFB4E1C2Q33402813-284D5155-79DF-45FE-931C-96956E2AC7F4Q33403381-8E7F3062-A3AA-4046-B9F1-43B9632BD022Q33404178-1D7A245D-318E-4889-A7F1-376317F79178Q33417258-B0659628-B7C1-400D-B59C-A9BE95558651Q33419807-0274B7E1-4E23-4180-953C-04E258A5DAD7Q33431891-51BB398F-6F19-47DF-8815-4864A0179027Q33441751-CFD2708A-6EE2-4644-B6C7-C2814921261DQ33443354-44ABACDD-133F-409B-8D6A-781A621CDE5AQ33894433-D4FE072C-E066-4AF9-A838-F366FC45D91DQ34017336-0CDCA4B0-1455-41A6-A6D8-6FEF0928059BQ34058113-81D60C1A-1DF9-46CB-A34F-314D1C1B6B16Q34161599-994224F8-CAF1-47B5-BDF4-61F2895B754BQ34201330-71FA35C5-9341-4821-9444-05BAD0D86CBCQ34223524-89BCD241-2267-4528-B94B-005E0A0665B4Q34355048-C30DA9F6-F20F-46D8-8054-2C092FE5E052Q34549913-2F66461C-3EF7-4BCB-ACBD-AFAB9B4B4481Q34611004-4C2AB014-CB34-4FD2-B83D-12BB1F2FF0BCQ34893606-78180EEB-1683-48C8-A031-EB3E3D3B936AQ35116202-A5EFE188-245C-4FF9-A0CA-5C31B897E0B2Q35177353-FA173456-E065-4826-8EE3-59CD64D2E5B7Q35811581-C1DE764C-F9F2-4FCE-881D-2B081276BD76Q36015294-48199BE8-AE4B-4B8F-A650-7B413AEE481CQ36167182-5662D751-6866-48D4-88CD-057F4E55821E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Direct thrombin inhibitors
@ast
Direct thrombin inhibitors
@en
Direct thrombin inhibitors
@nl
type
label
Direct thrombin inhibitors
@ast
Direct thrombin inhibitors
@en
Direct thrombin inhibitors
@nl
prefLabel
Direct thrombin inhibitors
@ast
Direct thrombin inhibitors
@en
Direct thrombin inhibitors
@nl
P2093
P3181
P356
P1476
Direct thrombin inhibitors
@en
P2093
Harry R Büller
Marcello Di Nisio
Saskia Middeldorp
P304
P3181
P356
10.1056/NEJMRA044440
P407
P577
2005-09-08T00:00:00Z